DFX Intelligence
Cofactor Genomics
Venture-backed company · Stage unknown
As of · the latest observation of this company; each round carries its own date
As of · the latest observation of this company; each round carries its own date
3 additional investors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 6 investorsnamed
6 investors on record.
The investors already on the cap table shape who leads the next round.
Drawing the relationship network…
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 6
Financing history
1 round
- Jun 14, 2017Form D equity offering · $10.7M (form d sold)Menlo Ventures via Mark Aaron SiegelDcvc via Matthew OckoFact Form D · “Cofactor Genomics, Inc. Form D, first filed 2017-06-28”
Investors on record
6 edges
- Y Combinator portfolio listing Fact ycombinator.com
- Tenoneten portfolio listing Fact tenoneten.com
- Ascension Ventures portfolio listing Fact ascensionventures.org
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.none on record
Outcome stated by investors
Listed on 4 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.
Evidence: 4 listingseach firm's own card, as read
- Status not stated on Y Combinator · the firm's card prints no outcome · read Oct 1, 2026 ycombinator.com“Cofactor Genomics”
- Status not stated on Tenoneten · the firm's card prints no outcome · read Sep 30, 2026 tenoneten.com“Cofactor Genomics”
- Status not stated on Ascension Ventures · the firm's card prints no outcome · read Sep 17, 2026 ascensionventures.org“Cofactor Genomics Inc”
1 more listing counted above; the firms are named with a plan.
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.none on record
No lender position matched to this company.
People
0 officers, 0 directors
No officer or director on record.
Timeline
0 events
No dated event on record.
Evidence
7 observations
Every observation on this company
- Listed on portfolio page: Y Combinator Oct 1, 2026 Fact Firm website
- Listed on portfolio page: Tenoneten Sep 30, 2026 Fact Firm website
- Listed on portfolio page: Ascension Ventures Sep 17, 2026 Fact Firm website
- Listed on portfolio page: Sep 16, 2026 Fact Firm website
- Listed on portfolio page: Tenoneten Sep 16, 2026 Fact Firm website
- Listed on portfolio page: Sep 15, 2026 Fact Firm website
- Listed on portfolio page: Tenoneten Sep 12, 2026 Fact Firm website
Relationships across DFX
on 1 other DFX graph
Across the graphs
Cofactor Genomics is the same institution as 1 record in Private Equity.
Private Equity1
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…